Cenra

Cenra Quick Ratio

The Quick Ratio (Acid Test) of Cenra (3716.TW) as of Oct 24, 2026 is 0.14. In the previous year, Quick Ratio (Acid Test) was 1.32 — a change of -89.71% (lower).

Quick Ratio

0.14

YoY

-89.71%

Last updated:

Quick Ratio (Acid Test) of Cenra is 2025 0.14 . Quick Ratio (Acid Test) of Cenra was 2024 1.32 . It decreases by -89.71% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cenra Stock analysis

What does Cenra do? Cenra Inc generates revenue through its subsidiaries that develop, manufacture, and sell pharmaceuticals, agricultural and livestock drugs, personal hygiene, and health products. The company offers human medicines including prescription, over-the-counter, and disease treatment products, medical equipment such as blood pressure monitors and blood glucose meters, animal medicines and feed additives, and daily necessities like oral hygiene products, hand sanitizers, and skin care items. These products are sold under the company's own brand portfolio, targeting consumers, healthcare providers, and veterinary markets. The company's business model focuses on integrated product development and distribution across multiple health and wellness segments. Cenra Inc's product segments include human pharmaceuticals, medical devices, animal health solutions, and personal care items. The human medicine segment covers prescription and over-the-counter drugs, while medical devices include blood pressure monitors and artificial joints. Animal health products consist of medicines, supplementary feeds, and feed additives for disease prevention and nutrition. Personal care products range from oral hygiene to skin care, targeting individual consumers seeking health and wellness solutions. The company's revenue streams are derived from direct sales of these diverse product categories to end-users and healthcare institutions. The company's subsidiaries handle the full value chain from development to sales, ensuring control over product quality and market positioning. By offering a comprehensive range of health-related products, Cenra Inc serves multiple customer segments including individual consumers for personal care, hospitals and clinics for medical equipment, and veterinary clinics for animal health products. This diversified approach allows the company to leverage cross-selling opportunities and maintain steady revenue streams across different market segments. Cenra is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cenra stock

Quick Ratio (Acid Test) of Cenra is 0.14 in 2025.

Quick Ratio (Acid Test) of Cenra changed from 1.32 to 0.14, representing a -89.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Cenra since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Cenra with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Cenra

All Key Metrics — Cenra